Nu Skin Enterprises, Inc.  

(Public, NYSE:NUS)   Watch this stock  
Find more results for NUS
61.37
-0.95 (-1.52%)
Jun 19 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 61.32 - 62.46
52 week 32.36 - 63.57
Open 62.39
Vol / Avg. 344,363.00/882,543.00
Mkt cap 3.58B
P/E 16.66
Div/yield 0.30/1.96
EPS 3.68
Shares 58.41M
Beta 1.28
Inst. own 91%
Jul 22, 2013
Q2 2013 Nu Skin Enterprises Earnings Release Add to calendar
May 2, 2013
Q1 2013 Nu Skin Enterprises Earnings Conference Call - Webcast
Apr 22, 2013
Q1 2013 Nu Skin Enterprises Earnings Release
Apr 9, 2013
Nu Skin Enterprises at Telsey Advisory Group Spring Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 9.87% 10.22%
Operating margin 15.03% 15.71%
EBITD margin - 17.61%
Return on average assets 18.45% 20.68%
Return on average equity 36.07% 38.06%
Employees 3,733 -
Carbon Disclosure Rating - -

Address

75 West Center Street
PROVO, UT 84601
United States - Map
+1-801-3451000 (Phone)
+1-801-3455999 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Nu Skin Enterprises, Inc. is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively. As of December 31, 2012, the Company had more than 950,000 distributors. The Company has two primary product categories, each operating under its own brand. It markets its personal care products under the Nu Skin brand and its nutritional supplements under the Pharmanex brand. During the year ended December 31, 2012, approximately 89% of its revenues came from its markets outside of the United States. The Company's ageLOC skin care products accounted for 23% of its total revenue and 43% of Nu Skin sales during the year ended December 31, 2012.

Officers and directors

Steven J. Lund Executive Chairman of the Board
Age: 59
Bio & Compensation  - Reuters
M. Truman Hunt President, Chief Executive Officer, Director
Portrait. Age: 53
Bio & Compensation  - Reuters
Ritch N. Wood Chief Financial Officer
Age: 47
Bio & Compensation  - Reuters
Daniel R. Chard President - Global Sales and Operations
Age: 48
Bio & Compensation  - Reuters
Scott E. Schwerdt President, Americas Region
Age: 55
Bio & Compensation  - Reuters
Joseph Y. Chang Ph.D. Executive Vice President - Product Development, Chief Scientific Officer
Age: 60
Bio & Compensation  - Reuters
D. Matthew Dorny General Counsel, Secretary
Portrait. Age: 48
Bio & Compensation  - Reuters
Daniel W. Campbell Lead Independent Director
Age: 57
Bio & Compensation  - Reuters
Blake M. Roney Director
Bio & Compensation  - Reuters
Nevin N. Andersen Independent Director
Age: 71
Bio & Compensation  - Reuters